CD209, CD163, CSF1, and MMD were related to M2 macrophage proportions in cutaneous melanoma, breast carcinoma, head and neck squamous cell carcinoma, hepatocellular carcinoma, prostate cancer, renal cancer, and lung adenocarcinoma (Figures 7A–D). This evidence concerns the gene CD163 and head and neck squamous cell carcinoma.